Cargando…

Type I Interferon Signature in Primary Antiphospholipid Syndrome: Clinical and Laboratory Associations

Background: Increased expression of type I interferon (IFN)-regulated genes has been described in blood and tissue cells from patients with systemic lupus erythematosus (SLE) and other rheumatic disorders. Only isolated studies have examined the type I IFN gene expression in antiphosholipid syndrome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palli, Eleni, Kravvariti, Evrydiki, Tektonidou, Maria G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428719/ https://www.ncbi.nlm.nih.gov/pubmed/30930907 http://dx.doi.org/10.3389/fimmu.2019.00487

Ejemplares similares

Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment
por: Tektonidou, Maria G.
Publicado: (2018)

Editorial: Primary Antiphospholipid Syndrome
por: Serrano, Antonio, et al.
Publicado: (2020)

Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome
por: Zhou, Zhuochao, et al.
Publicado: (2021)

Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques
por: Bolla, Eleana, et al.
Publicado: (2023)

Antiphospholipid Antibodies and Antiphospholipid Syndrome during Pregnancy: Diagnostic Concepts
por: Levy, Roger A., et al.
Publicado: (2015)

Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form
por: Kolitz, Tamara, et al.
Publicado: (2019)

Comparison of non-criteria antiphospholipid syndrome with definite antiphospholipid syndrome: A systematic review
por: Pires da Rosa, Gilberto, et al.
Publicado: (2022)

Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: Diagnostic value added
por: Liu, Xiangjun, et al.
Publicado: (2022)

Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic Sclerosis
por: Vlachogiannis, Nikolaos I., et al.
Publicado: (2020)

Renal Involvement in Antiphospholipid Syndrome
por: Turrent-Carriles, Alonso, et al.
Publicado: (2018)

Complement in the Pathophysiology of the Antiphospholipid Syndrome
por: Chaturvedi, Shruti, et al.
Publicado: (2019)

The role of the Nocebo effect in the use of biosimilars in routine rheumatology clinical practice
por: Kravvariti, Evrydiki, et al.
Publicado: (2019)

Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults
por: Tektonidou, Maria G, et al.
Publicado: (2019)

Trained Immunity in Primary Sjögren’s Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype
por: Huijser, Erika, et al.
Publicado: (2022)

Type I Interferon Induction in Cutaneous DNA Damage Syndromes
por: Klein, Benjamin, et al.
Publicado: (2021)

Heterogeneity of the Type I Interferon Signature in Rheumatoid Arthritis: A Potential Limitation for Its Use As a Clinical Biomarker
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2018)

Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus
por: Gerosa, Maria, et al.
Publicado: (2016)

Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients
por: Li, Siting, et al.
Publicado: (2023)

Assessment of type I interferon signatures in undifferentiated inflammatory diseases: A Japanese multicenter experience
por: Miyamoto, Takayuki, et al.
Publicado: (2022)

Dynamics of Type I and Type II Interferon Signature Determines Responsiveness to Anti-TNF Therapy in Rheumatoid Arthritis
por: Iwasaki, Takeshi, et al.
Publicado: (2022)

The role of the intestinal microbiome in antiphospholipid syndrome
por: van Mourik, Dagmar J. M., et al.
Publicado: (2022)

An update on the biologics for the treatment of antiphospholipid syndrome
por: Yun, Zelin, et al.
Publicado: (2023)

Stress perfusion Cardiac Magnetic Resonance in Patients with Antiphospholipid Syndrome
por: Tektonidou, Maria G., et al.
Publicado: (2018)

Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature
por: Sugrue, Jamie A., et al.
Publicado: (2021)

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications
por: Tedesco, Francesco, et al.
Publicado: (2018)

Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome
por: Truglia, Simona, et al.
Publicado: (2022)

Type I Interferon in Human Autoimmunity
por: Niewold, Timothy B.
Publicado: (2014)

Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Meroni, Pier Luigi, et al.
Publicado: (2019)

Exosome-Contained APOH Associated With Antiphospholipid Syndrome
por: Tan, Yuan, et al.
Publicado: (2021)

PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid Syndrome
por: Willis, Rohan, et al.
Publicado: (2022)

The Dual Nature of Type I and Type II Interferons
por: Lee, Amanda J., et al.
Publicado: (2018)

Type I Interferons as Regulators of Lung Inflammation
por: Makris, Spyridon, et al.
Publicado: (2017)

Restriction of the Global IgM Repertoire in Antiphospholipid Syndrome
por: Pashova, Shina, et al.
Publicado: (2022)

Pyroptosis-triggered pathogenesis: New insights on antiphospholipid syndrome
por: Tan, Yuan, et al.
Publicado: (2023)

Immunoglobulin A Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for the Diagnosis of Antiphospholipid Syndrome in a Chinese Population
por: Hu, Chaojun, et al.
Publicado: (2020)

Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome
por: Álvarez-Rodríguez, Lorena, et al.
Publicado: (2019)

Patterns of Recurrent Thrombosis in Primary Antiphospholipid Syndrome—Multicenter, Real-Life Long-Term Follow-Up
por: Niznik, Stanley, et al.
Publicado: (2022)

Oxidative stress and endogenous DNA damage in blood mononuclear cells may predict anti-SARS-CoV-2 antibody titers after vaccination in older adults
por: Ntouros, Panagiotis A., et al.
Publicado: (2022)

Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)
por: Savelli, Stephanie L., et al.
Publicado: (2019)

Type I Interferon Receptor on NK Cells Negatively Regulates Interferon-γ Production
por: Lee, Amanda J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u9mfibqie651ago636tpucnmqd